All Sauce from Weekly Sauce:

While it appears that Black Americans were more hesitant than white Americans to roll up their sleeves when the COVID-19 vaccines launched last year, that unwillingness has lessened. Following 1,200 U.S. adults through much of the pandemic, researchers found Black people were more likely to change their negative thinking about COVID-19 vaccination compared to white…  read on >  read on >

The coronavirus can leave more than 40% of children hospitalized for COVID-19 with headaches and other lingering neurological symptoms, a new study claims. And the kids who developed these headaches or experienced an altered mental status known as acute encephalopathy were more likely to need intensive care, said researchers from the University of Pittsburgh Medical…  read on >  read on >

A brain implant that helps control severe epilepsy in adults may do the same for children who suffer from unrelenting seizures, new research suggests. The study is one of the first to examine the responsive neurostimulation (RNS) system in children. RNS has already been approved by the U.S. Food and Drug Administration for adult patients…  read on >  read on >

Worrying can take a toll on your psyche, but new research suggests that when middle-aged men fret too much, they face a higher risk for developing diabetes, heart disease or stroke down the road. And this increase in risk is on par with the health risks linked to heavy drinking, the findings showed. “Our findings…  read on >  read on >

MONDAY, Jan. 24, 2022 (healthDay News) — The U.S. Food and Drug Administration may soon curtail the use of two monoclonal antibody treatments that do not appear to work against the highly contagious Omicron variant. The treatments made by Regeneron and Eli Lilly performed well against earlier variants, but only GlaxoSmithKline’s antibody therapy has stayed…  read on >  read on >